Skip to main content

Institutional intelligence for ASTRAZENCA PHARMA INDIA LTD.

Cross-view mutual fund activity and super-investor shareholding · Jun 2026 SHP.

Ownership breakdown

Category totals from the official quarterly Shareholding Pattern filing (Jun 2026). Sums to 100.00%.

  • Promoters75.00%
  • FII2.68%
  • Mutual Funds6.01%
  • DII (ex-MF)0.07%
  • Retail & others16.24%
  • 1% Club 11.67%(subset)

Super Investors and 1% Club names below are disclosed holders at or above 1%. They are subsets of the categories above, not additive. View filing

Holder details (≥1% disclosed names)

Promoters

Promoter & promoter group

75.00%1 named
HolderStakeSharesValue (₹ Cr)
75.00%1,87,50,000

1% Club — Individuals & others

Non-promoter ≥1% holders not matched to a curated profile

11.67%6 named

Retail & others

Holders below 1% disclosure threshold and public non-institutions

16.24%

SEBI requires naming only shareholders with ≥1% stake. The remaining 16.24% includes retail investors, small HNIs, employee trusts, and other holders below the disclosure threshold — aggregated in the official filing.

Mutual Funds

Domestic mutual funds & UTI

6.01%No names

No named holders ≥1% in this bucket.

FII / FPI

Foreign portfolio investors

2.68%No names

No named holders ≥1% in this bucket.

DII (other)

Insurance, banks, AIF, other domestic institutions

0.07%No names

No named holders ≥1% in this bucket.

Super Investors

Curated tracked investor profiles

No names

No curated super investor holds ≥1% in the latest filing. See FII, DII, and mutual fund holders in the sections above.

Shareholding data sourced from NSE/BSE regulatory filings. Category chart uses official filing totals; named holder lists include every disclosed ≥1% position. Not investment advice. See our disclaimer and methodology.